PMID: 9433953Jan 20, 1998Paper

Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteers

International Journal of STD & AIDS
L DorrellE Ong

Abstract

To investigate the clinical and serological responses to an inactivated influenza vaccine (split-virion A/Singapore/6/86-like strains H1N1 (15 ug HA), A/Beijing/353/89-like H3N2 (15 ug HA) and B/Yamagata/16/88-like strain (15 ug HA): MFV-JECT, Merieux, UK) in persons with HIV infection, diabetes, obstructive lung diseases, elderly adults and healthy volunteers. Forty-nine HIV-infected persons received 2 doses of the vaccine at one-month intervals; 34 healthy volunteers, 30 elderly persons, 29 with insulin and non-insulin diabetes and 14 with obstructive airways diseases were vaccinated with one single dose between October 1992 to January 1993. Serological testing of antibody responses was done using haemagglutination assay. Beta2-microglobulin in HIV-infected persons was measured using radioimmunodiffusion between 1st and 2nd dose. Fructosamine levels in diabetic persons were assessed for diabetic control and peak expiratory flow rate (PEFR) was self monitored in persons with lung diseases. All groups apart from the elderly filled in a symptom score chart for the first 5 days following vaccination. A 4-fold rise in titre equal to or more than 1:64 to all the 3 antigens occurred in 20 (58.8%) of healthy volunteers compared with ...Continue Reading

Associated Clinical Trials

Citations

Jan 30, 2003·American Journal of Public Health·Leonard E Egede, Deyi Zheng
Jun 3, 2005·Clinical Medicine & Research·Kenneth A MusanaKurt D Reed
May 22, 2007·Journal of Clinical Immunology·V BaldoUNKNOWN Family Medicine Group
Jul 24, 2001·Immunological Investigations·A BanzhoffA Muszer
Jun 1, 2008·Expert Review of Respiratory Medicine·Catherine W M Ong, Paul Ananth Tambyah
Jan 27, 2004·Journal of Neuroscience Research·Oleg Broytman, James S Malter
Sep 20, 2005·American Journal of Preventive Medicine·Charles M HelmsUNKNOWN National Vaccine Advisory Committee
Jan 25, 2005·Progress in Transplantation : Official Publication, North American Transplant Coordinators Organization ... [et Al.]·Mary S HayneyRobert B Love
Oct 19, 2000·Journal of the American Geriatrics Society·M M ZadehK Fukuda
Dec 6, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Mizuho SatoHiroshi Suzuki
Dec 28, 2000·AIDS·P S SullivanUNKNOWN Adult and Adolescent Spectrum of HIV Disease Investigators
Oct 2, 2004·The Journal of International Medical Research·G V ZuccottiE Riva
Jun 27, 2018·The Cochrane Database of Systematic Reviews·Zoe KopsaftisPhillippa Poole
Nov 8, 2002·Drugs·Eelko HakTheo J M Verheij
Jan 27, 2006·The Cochrane Database of Systematic Reviews·P J PooleC J Cates
Jun 10, 2020·Expert Review of Vaccines·Thomas VerstraetenBradford D Gessner
Jul 3, 2002·The Nurse Practitioner·Michelle Kennedy Prisco
Mar 7, 2021·International Journal of Environmental Research and Public Health·Sylwia KałuckaIzabela Grzegorczyk-Karolak
Apr 12, 2002·The Lancet Infectious Diseases·Cassandra D SalgadoFrederick G Hayden

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.